<html>
<body>
<font size=3 color="#000080"><b>Pois é...<br>
Não me consta que os convênios com o MST influenciem as citações dos
professô-publicadô.<br>
L</font><font color="#000080">.E.<br><br>
</b></font>=========================================<br><br>
<br>
<div align="right">
<a href="http://www.medscape.com/viewarticle/580356" eudora="autourl">
http://www.medscape.com/viewarticle/580356<br><br>
<br>
</a></div>
<div align="center"><font size=3><b>Industry-Sponsored Trials More Widely
Cited Than Not-for-Profit Studies<br><br>
from
<a href="http://www.theheart.org">Heart</a>
<a href="http://www.theheart.org"><i>wire</a></i> a professional news
service of WebMD<br><br>
<br><br>
Michael O'Riordan<br><br>
</b>
<img src="cid:7.1.0.9.0.20080917163302.01d582c0@infolink.com.br.0" width=77 height=8 alt="advertisement">
</b><br><br>
</div>
<b>Information from Industry<br><br>
<a href="http://as.webmd.com/event.ng/Type=click&FlightID=28454&AdID=47532&TargetID=7839&Values=205&Redirect=http:/www.medscape.com/infosite/pointofcaretesting?src=0_0_ad_rct">
The Institute for Advances in Point-of-Care Testing<br>
</a></b>Keep up with emerging trends in glycemic control, anticoagulation
management, and other areas of point-of-care testing, to help reduce
costs, enhance the efficacy of healthcare management, and improve patient
outcomes. <br><br>
<br><br>
September 10, 2008 (Boston, MA) Cardiovascular clinical trials
sponsored by industry are more likely to be cited in future medical
publications than studies performed by not-for-profit organizations, a
new study has shown [1]. Efforts should be made to ensure that important
trials conducted by government agencies, such as the <b>National
Institutes of Health</b> (NIH), are more widely disseminated to the
cardiovascular community, say investigators.<br><br>
"As a researcher, my core belief is that high-quality research gets
done by the NIH and by industry, and the quality of our patients' lives
will improve if this information is transmitted to the medical
community," senior investigator <b>Dr Paul Ridker</b> (Brigham and
Women's Hospital, Boston, MA) told <b>heart<i>wire</i></b>. "What we
observed is that the translation to practice is more rapid and thorough
for industry-funded studies. We hope there can be a mechanism to do a
better job promoting the findings of federally funded studies as
well."<br><br>
The results of the study, with first author <b>Dr David Conen</b>
(Brigham and Women's Hospital), are published online September 8, 2008 in
<i>Circulation</i>.<br><br>
<b>Responding to High-Quality Work<br><br>
</b>In 2006, Ridker and colleagues published a study showing that
cardiovascular clinical trials funded by for-profit sponsors were
significantly more likely to have positive results than trials reported
by not-for-profit funding sources. He told <b>heart<i>wire</i></b> that
while the initial publication has an impact on clinical practice, how
often the paper is cited in subsequent medical publications also has an
effect on physician behavior. <br><br>
The purpose of this study, explained Ridker, was to examine how the
cardiovascular community responded to high-quality research funded by
different sources. To do so, the Harvard researchers analyzed 303
consecutive superiority trials of cardiovascular medicine published
between January 1, 2000 and July 30, 2005 in the <i>Journal of the
American Medical Association</i>, the <i>Lancet</i>, and the <i>New
England Journal of Medicine</i>. They then determined the number of
citations per publication per year, a metric used to ascertain how the
medical community was responding to the findings. <br><br>
Investigators observed that industry-funded studies had more citations
per publication per year than NIH- or other federally funded studies.
This was true in all settings except for one: industry-funded studies
were not cited as frequently when the studies failed to show a
benefit.<br><br>
<br><br>
<br>
<div align="center"><b>Citations Per Publication Per Year According to
Funding Source</b> <br>
</div>
(...)<br><br>
<br><br>
<br><br>
<br><br>
<br><br>
<br>
============================</font></body>
</html>